Analysts think CODX stock price could increase by 74%
Aug 01, 2024, 6:27 AM
18.38%
What does CODX do
Co-Diagnostics, Inc., based in Salt Lake City, Utah, specializes in developing molecular diagnostics for detecting infectious diseases, cancer screening, and agricultural uses, and went public in 2017. The company designs and distributes reagents and equipment, including a developing portable PCR device, for simplified molecular testing in various settings.
3 analysts think CODX stock price will increase by 74.36%. The current median analyst target is $2.04 compared to a current stock price of $1.17. The lowest analysts target is $2.02 and the highest analyst target is $2.10.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.